Imodium (Loperamide Hydrochloride)

Loperamide, the active ingredient in Imodium, binds to peripheral µ‑opioid receptors in the gut wall. This binding inhibits the release of acetylcholine and prostaglandins, leading to reduced peristalsis, prolonged intestinal transit time, and increased absorption of water from the intestinal lumen.

The appropriate dose of Imodium is set by a healthcare professional based on the patient’s age, weight, severity of symptoms, and clinical response. Over‑the‑counter labeling provides general guidance, but the prescriber’s recommendation should always be followed for safe use.

Safety data for Loperamide in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their physician before using Imodium.

To order Imodium, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

The primary alternative to Imodium is diphenoxylate‑atropine (Lomotil). Both agents reduce intestinal motility, but diphenoxylate has central opioid activity and is prescription‑only in many regions, whereas Loperamide remains OTC with minimal central effects. Choice depends on severity, regulatory status, and patient tolerance.

Imodium should be stored at ambient temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Imodium is taken orally with a glass of water. The initial dose is usually taken at the onset of diarrhea, followed by additional doses as directed by a healthcare professional. It can be taken with or without food, but adequate fluid intake is recommended.

Serious risks include severe constipation that can lead to bowel obstruction, cardiac arrhythmias especially when combined with CYP3A4 or P‑gp inhibitors, and rare allergic reactions such as rash, swelling, or anaphylaxis. Immediate medical attention is required if any of these occur.

Imodium should be avoided in patients with known hypersensitivity to loperamide, in cases of acute dysentery, bacterial enterocolitis with fever or blood in stool, and in children younger than the age specified on the label. Caution is also advised for individuals with severe hepatic impairment.